Recruiting Sjogrens Syndrome Studies in Tustin
Nipocalimab in Moderate to Severe Sjogren's Disease
The purpose of this study is to evaluate the clinical efficacy and safety of nipocalimab in participants with moderate to severe Sjogren's disease (SjD)....
A Study of RSLV-132 in Females With Sjögren's Disease
The goal of this clinical study is to learn if RSLV-132 improves the symptoms of SS in adults. It will also learn about the safety of RSLV-132. The main questions it aims to answer are: * Does RSLV-1...
About Sjogrens Syndrome Clinical Trials in Tustin
Sjogren's syndrome is a chronic autoimmune disorder in which the immune system attacks the glands that produce moisture, causing dry eyes and dry mouth. It can also affect joints, thyroid, kidneys, and other organs. Treatment focuses on relieving symptoms and may include immunosuppressive medications.
There are currently 2 sjogrens syndrome clinical trials recruiting participants in Tustin, CALIFORNIA. These studies are seeking a combined 706 participants. Research is being sponsored by Janssen Research & Development, LLC, Resolve Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Sjogrens Syndrome Clinical Trials in Tustin — FAQ
Are there sjogrens syndrome clinical trials in Tustin?
Yes, there are 2 sjogrens syndrome clinical trials currently recruiting in Tustin, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tustin?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tustin research site will contact you about next steps.
Are clinical trials in Tustin free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tustin studies also compensate for your time and travel.
What sjogrens syndrome treatments are being tested?
The 2 active trials in Tustin are testing new therapies including novel drugs, biologics, and treatment approaches for sjogrens syndrome.
Data updated March 2, 2026 from ClinicalTrials.gov